{
    "2020-08-10": [
        [
            {
                "time": "2020-07",
                "original_text": "2020年7月疫苗批签发数据：批签发维持高速增长 流感疫苗恢复批签发",
                "features": {
                    "keywords": [
                        "疫苗",
                        "批签发",
                        "高速增长",
                        "流感疫苗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07",
                "original_text": "医药生物行业周报：中报窗口期继续看好业绩高增长板块 持续推荐有实力能兑现的疫苗公司",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中报",
                        "业绩高增长",
                        "疫苗公司"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07",
                "original_text": "医药行业周报：建议关注药店 关注业绩高增长、政策变化和估值性价比",
                "features": {
                    "keywords": [
                        "医药行业",
                        "药店",
                        "业绩高增长",
                        "政策变化",
                        "估值性价比"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-07",
                "original_text": "关键指标异常，多只高位股下跌，37只热门股回调超20%",
                "features": {
                    "keywords": [
                        "关键指标",
                        "高位股",
                        "下跌",
                        "热门股",
                        "回调"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-07",
                "original_text": "获阿斯利康新冠疫苗独家授权，康泰生物高位跌停",
                "features": {
                    "keywords": [
                        "阿斯利康",
                        "新冠疫苗",
                        "独家授权",
                        "康泰生物",
                        "高位跌停"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-07",
                "original_text": "时代医药周报 | 武汉出台重点监控目录，辅助用药限量降价大势所趋",
                "features": {
                    "keywords": [
                        "时代医药",
                        "武汉",
                        "重点监控",
                        "辅助用药",
                        "限量降价"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-08-07",
                "original_text": "A股融资融券日报：两融余额减少84.42亿元（8月7日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "减少"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-07",
                "original_text": "沃森生物大股东高位套现，转身3亿参与康泰生物定增！",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "大股东",
                        "高位套现",
                        "康泰生物",
                        "定增"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-07",
                "original_text": "康泰生物获海外疫苗独家授权，跌停接涨停，真是“新冠疫苗股”吗？",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "海外疫苗",
                        "独家授权",
                        "跌停",
                        "涨停",
                        "新冠疫苗股"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}